Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

18.09.2017 | original article | Ausgabe 9-10/2019

Wiener Medizinische Wochenschrift 9-10/2019

In vitro activity of linezolid alone and combined with other antibiotics against clinical enterococcal isolates

Zeitschrift:
Wiener Medizinische Wochenschrift > Ausgabe 9-10/2019
Autoren:
MSc Mahtab Beitdaghar, PhD Roya Ahmadrajabi, PhD Afsaneh Karmostaji, PhD Fereshteh Saffari

Summary

Background

The increasing incidence of antimicrobial resistance has led to research on finding new antimicrobial agents or identifying drug combinations with synergistic effects. Enterococcal infections, particularly those associated with vancomycin-resistant enterococci (VREs), are therapeutic problems. Linezolid (LZD), an oxazolidinone antibiotic, shows good activity against Gram-positive bacteria including enterococci. To avoid the emergence of linezolid-resistant subpopulations and achieve enhanced activity or bactericidal effect, the use of combined therapy has been considered.

Methods

The in vitro activity of LZD in combination with five different antibiotics was evaluated using a microdilution checkerboard method and time-kill study against 12 clinical enterococcus isolates.

Results

With the checkerboard method, LZD plus doxycycline (DX) had the highest frequency among all synergistic combinations. This combination and the one of LZD plus ceftriaxone (CRO) were the most frequent effective combinations against VREs. Time-kill studies using selected synergistic combinations—LZD + DX and LZD + CRO—showed an indifferent interaction. One tested combination of LZD + rifampicin showed antagonism.

Conclusions

Antagonistic interactions in combinations containing LZD are rare. LZD + DX and LZD + CRO may be beneficial in the treatment of VREs. However, more time-kill studies as well as in vivo experiments are required.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 9-10/2019

Wiener Medizinische Wochenschrift 9-10/2019 Zur Ausgabe